
A combination of two medications designed to enhance sexual arousal, increase sensitivity, boost energy, and intensify pleasure. This compounded formulation may also help address issues with low libido and reduce anxiety related to sexual performance.
Oxytocin is a love hormone that makes the body radiate sexual desire, attachment, and temptation like a teenager again. It is a hormone secreted by the supraoptic and paraventricular nuclei of the hypothalamus and stored in the posterior pituitary.
Bremelanotide — Melanocortin Receptor Agonist
Bremelanotide PT-141 is a new and innovative treatment for erectile dysfunction and other sexual dysfunctions in men, with a clinical success rate of over 80%. It is a peptide being studied for its potential use in treating sexual dysfunction in both men and women.
Men
Central Mechanism of Action




Oxytocin / PT-141 is a compounded formulation combining two distinct compounds — Oxytocin (the love hormone) and Bremelanotide PT-141 (a melanocortin receptor agonist) — into a single prescription treatment. It is designed to enhance sexual arousal, increase sensitivity, boost energy, intensify pleasure, address low libido, and reduce anxiety related to sexual performance. The two compounds work through entirely different pathways, creating a more comprehensive effect than either achieves alone.
Oxytocin works hormonally and emotionally — it is naturally released during intimacy and is associated with social bonding, sexual desire, attachment, and the feeling of connection with a partner. PT-141 (Bremelanotide) works neurologically — it is a melanocortin receptor agonist that directly stimulates the central nervous system to increase libido and sexual arousal, independently of vascular mechanisms. Together, they address the hormonal, emotional, and neurological dimensions of sexual dysfunction simultaneously.
This combination is suited for both men and women experiencing sexual dysfunction, low libido, reduced arousal, or performance anxiety. For women, PT-141 has been approved for treating Hypoactive Sexual Desire Disorder (HSDD) in premenopausal patients. For men, it offers an alternative to PDE5 inhibitors like sildenafil or tadalafil — particularly for those who do not respond adequately to those medications. The addition of Oxytocin enhances the emotional bonding and intimacy dimension for both.
Oxytocin is produced naturally by the hypothalamus and stored in the posterior pituitary. It is released during intercourse in both men and women and is believed to be involved in sexual bonding, mating, and social behaviors. In this formulation, it amplifies feelings of desire, attachment, and emotional temptation — making intimacy feel more connected and meaningful. It works alongside PT-141's neurological action to create a fuller, more layered sexual experience.
PT-141 (Bremelanotide) is a melanocortin receptor agonist that stimulates the release of melanocortin — a hormone involved in sexual arousal and erections. It acts directly on the central nervous system rather than on blood vessels, which makes it effective even when vascular ED treatments have failed. Clinical trials have shown a success rate of over 80%. It increases libido, boosts the frequency of morning erections, and directly heightens sexual desire through the nervous system.
Yes. This compounded formulation may help reduce anxiety related to sexual performance — a common psychological factor that compounds physical dysfunction and creates a self-reinforcing cycle of difficulty. Oxytocin's role in reducing stress and promoting feelings of safety and connection can help ease performance-related anxiety, while PT-141's direct stimulation of desire may help overcome the hesitancy that anxiety creates.
Yes. Bremelanotide (PT-141) has been FDA-approved under the brand name Vyleesi specifically for treating Hypoactive Sexual Desire Disorder (HSDD) in premenopausal women. The compounded version used in this formulation is not itself FDA-approved as a compounded product, but it is based on the same active compound and prepared by a licensed compounding pharmacy — Strive Pharmacy — under a valid prescription from a licensed provider.
PT-141 may cause temporary nausea, flushing, or headache, and can cause skin darkening (hyperpigmentation) over time with prolonged use. Oxytocin should be used with caution by patients with cardiovascular conditions, as it can affect heart rhythm and blood pressure. Both compounds require a prescription and provider oversight. Disclose all current medications and medical conditions to your provider at intake, as interactions are possible — particularly with nitrate medications for patients also using tadalafil or sildenafil.
Describe the item or answer the question so that site visitors who are interested get more information. You can emphasize this text with bullets, italics or bold, and add links.
Yes. Oxytocin / PT-141 is a prescription-only compounded medication. At Testosteroneshots.com, the full process — medical intake, provider evaluation, and prescription — is completed entirely online via telemedicine. No clinic visits required. You must be 18 or older to order.

© 2026, TestosteroneShots.com PC
text (323)-283-9219
638 1/2 N Robertson Blvd, West Hollywood, CA 90069
The information and products provided on this website are for educational and wellness purposes only and are not intended to diagnose, treat, cure, or prevent any disease. All treatments require evaluation and approval by a licensed healthcare provider through a telemedicine consultation. Individual results may vary, and products carry potential risks and side effects. Certain products may not be evaluated by the U.S. Food and Drug Administration (FDA) unless explicitly stated. Services are provided by licensed physicians and nurse practitioners in states where they are authorized to practice, including California, Florida, Nevada, and other participating states. This service is not intended for medical emergencies. If you are experiencing an emergency, call 911 or seek immediate medical care. We take reasonable measures to protect personal health information in accordance with applicable privacy laws, including HIPAA. By using this website or its services, you agree to our Terms of Service, Privacy Policy, and Telehealth Consent. You must be 18 years of age or older to use this service.